About Zen-Bio
Zen-Bio is a Healthcare company based in Durham (United States) founded in 1995, and was acquired by BioIVT in August 2024. Cell-based solutions are provided to accelerate therapy discovery and development. Its website zen-bio.com draws about 11 thousand monthly visits. Zen-Bio offers products and services including Blood/Serum Products, Cell Extracts, Human Exosomes, Labware, and Media. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and In Vitro Assays. Its legal entity is ZenBio, Inc. Its competitors include Anabios, Quiver Bioscience and Rules-Based Medicine; 2 of its 3 listed competitors have raised funding.
Company details
Founded in 1995 and based in Durham, United States, Zen-Bio operates in the biotechnology sector, focusing on metabolic diseases and cosmeceuticals. Human cell-based products, including cells, tissues, and serum from diverse donor populations and disease states such as type II diabetes and hypertension, are supplied. Contract research services, cell-based assay development, custom consultations, cell characterization, and molecular biology services are offered to support therapy development.
Products & Services of Zen-Bio
Zen-Bio offers a comprehensive portfolio of products and services, including Blood/Serum Products, Cell Extracts, Human Exosomes, Labware, and Media.
Provides human and animal blood components for research use.
Offers extracts from human tissues for scientific studies.
Delivers exosomes from stem cells for regenerative research.
Supplies ECM coated plastics for cell culture applications.
Formulates media for optimal cell growth in experiments.
Provides kits for testing compounds in metabolic diseases.
Funding Insights of Zen-Bio
- Total Rounds 11
- Last Round Grant — $251,144
- First Round $228,954
(May 2008)
- Investors Count 1
Latest 10 of 11 funding rounds of Zen-Bio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2011 | $251,144 | Grant | – | – | |
| Oct 2010 | $1.89M | Grant | – | – | |
| Sep 2010 | $1.29M | Grant | – | – | |
| Sep 2010 | $1.29M | Grant | – | – | |
| Jul 2010 | $363,202 | Grant | – | – | |
| Apr 2010 | $227,197 | Grant | – | – | |
| Jan 2009 | $1.69M | Grant | – | – | |
| Sep 2008 | $1.38M | Grant | – | – | |
| Sep 2008 | $1.24M | Grant | – | – | |
| Sep 2008 | $206,649 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Zen-Bio
Zen-Bio has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and BioIVT.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Provider of in vitro diagnostic products and assay services | 2015 | bioivt.com | Westbury, United States |
Investor details for Zen-Bio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Zen-Bio
4 dated milestones of Zen-Bio across 29 years, from founding to its latest funding, stage changes and deals.
- Founded Zen-Bio is founded.
- Funding First funding round of $229K.
- Funding Latest funding round, Grant, of $251K.
- Exit Acquired by BioIVT.
Competitors of Zen-Bio
Zen-Bio has 3 listed competitors in our database, 2 of them funded. They include Anabios, Quiver Bioscience and Rules-Based Medicine.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| anabios.com | 2009 | San Diego, United States | $24.78M | 51 | Ex-vivo human tissue studies are performed for preclinical drug discovery. | |
| quiverbioscience.com | 2013 | Cambridge, United States | Developer of transformational medicines for neurological disorders | |||
| rulesbasedmedicine.com | 2002 | Austin, United States | $25M | Multiplexed immunoassays for protein biomarkers are developed via proprietary platform. |
Detailed competitors of Zen-Bio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Zen-Bio
The website of Zen-Bio (zen-bio.com) receives about 10.8K visits a month.
- Monthly visits10.8K
▼ 39.2% vs previous month
Websites whose visitors overlap most with Zen-Bio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| celprogen.com | 100% | #3,394,353 | View details | ||
| bdbiosciences.com | 97% | 331.8K | #154,504 | View details | |
| ingenuity.com | 97% | 24.3K | #619,156 | View details | |
| trevigen.com | 97% | View details | |||
| bioassaysys.com | 97% | 12.4K | #2,032,630 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 34 similar websites and full traffic analytics for Zen-Bio
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 34 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Zen-Bio (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Zen-Bio
Complete news archive for Zen-Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zen-Bio
Zen-Bio was founded in 1995 and raised its 1st funding round 13 years after it was founded.
Zen-Bio is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Founded in 1995 and based in Durham, United States, Zen-Bio operates in the biotechnology sector, focusing on metabolic diseases and cosmeceuticals. Human cell-based products, including cells, tissues, and serum from diverse donor populations and disease states such as type II diabetes and hypertension, are supplied. Contract research services, cell-based assay development, custom consultations, cell characterization, and molecular biology services are offered to support therapy development.
Zen-Bio's top competitors include Quiver Bioscience, Anabios and Rules-Based Medicine.
Zen-Bio offers Blood/Serum Products, Cell Extracts, Human Exosomes, Labware, and 2 more products and services.
Zen-Bio operates through Zenbio, Inc..
Yes. Zen-Bio was acquired by BioIVT in August 2024.